Outcomes | Mortality | AMI | Stroke | ESRF |
---|---|---|---|---|
Number of participants without outcome at baseline | 2866 | 2728 | 2716 | 2806 |
Overall Occurrences (%)* | 800 (27.9) | 362 (13.3) | 191 (7.0) | 218 (7.8) |
Median follow-up time, years [IQR] | 6.72 [4.17, 9.66] | 6.50 [3.93, 9.58] | 6.58 [4.02, 9.63] | 6.56 [4.00, 9.58] |
Occurrences by Quartile (%)* | Â | Â | Â | Â |
Q1 [108–400µmol/L] | 191 (6.6) | 88 (3.2) | 49 (1.8) | 34 (1.2) |
Q2 [400–493µmol/L] | 161 (5.6) | 81 (3.0) | 50 (1.8) | 31 (1.1) |
Q3 [493–580µmol/L] | 186 (6.5) | 87 (3.2) | 43 (1.6) | 51 (1.8) |
Q4 [580–1250µmol/L] | 262 (9.1) | 106 (3.9) | 49 (1.8) | 102 (3.6) |